Cargando…

Informed Decision-Making and Capabilities in Population-based Cancer Screening

Informed decision-making (IDM) is considered an important ethical and legal requirement for population-based screening. Governments offering such screening have a duty to enable invitees to make informed decisions regarding participation. Various views exist on how to define and measure IDM in diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolt, Ineke L L E, Schermer, Maartje H N, Bomhof-Roordink, Hanna, Timmermans, Danielle R M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883722/
https://www.ncbi.nlm.nih.gov/pubmed/36727101
http://dx.doi.org/10.1093/phe/phac023
_version_ 1784879565474103296
author Bolt, Ineke L L E
Schermer, Maartje H N
Bomhof-Roordink, Hanna
Timmermans, Danielle R M
author_facet Bolt, Ineke L L E
Schermer, Maartje H N
Bomhof-Roordink, Hanna
Timmermans, Danielle R M
author_sort Bolt, Ineke L L E
collection PubMed
description Informed decision-making (IDM) is considered an important ethical and legal requirement for population-based screening. Governments offering such screening have a duty to enable invitees to make informed decisions regarding participation. Various views exist on how to define and measure IDM in different screening programmes. In this paper we first address the question which components should be part of IDM in the context of cancer screening. Departing from two diverging interpretations of the value of autonomy—as a right and as an ideal—we describe how this value is operationalized in the practice of informed consent in medicine and translate this to IDM in population-based cancer screening. Next, we specify components of IDM, which is voluntariness and the requirements of disclosure and understanding. We argue that whereas disclosure should contain all information considered relevant in order to enable authentic IDM, understanding of basic information is sufficient for a valid IDM. In the second part of the paper we apply the capability approach in order to argue for the responsibility of the government to warrant equal and real opportunities for invitees for IDM. We argue that additional conditions beyond mere provision of information are needed in order to do so.
format Online
Article
Text
id pubmed-9883722
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-98837222023-01-31 Informed Decision-Making and Capabilities in Population-based Cancer Screening Bolt, Ineke L L E Schermer, Maartje H N Bomhof-Roordink, Hanna Timmermans, Danielle R M Public Health Ethics Original Articles Informed decision-making (IDM) is considered an important ethical and legal requirement for population-based screening. Governments offering such screening have a duty to enable invitees to make informed decisions regarding participation. Various views exist on how to define and measure IDM in different screening programmes. In this paper we first address the question which components should be part of IDM in the context of cancer screening. Departing from two diverging interpretations of the value of autonomy—as a right and as an ideal—we describe how this value is operationalized in the practice of informed consent in medicine and translate this to IDM in population-based cancer screening. Next, we specify components of IDM, which is voluntariness and the requirements of disclosure and understanding. We argue that whereas disclosure should contain all information considered relevant in order to enable authentic IDM, understanding of basic information is sufficient for a valid IDM. In the second part of the paper we apply the capability approach in order to argue for the responsibility of the government to warrant equal and real opportunities for invitees for IDM. We argue that additional conditions beyond mere provision of information are needed in order to do so. Oxford University Press 2022-10-03 /pmc/articles/PMC9883722/ /pubmed/36727101 http://dx.doi.org/10.1093/phe/phac023 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Articles
Bolt, Ineke L L E
Schermer, Maartje H N
Bomhof-Roordink, Hanna
Timmermans, Danielle R M
Informed Decision-Making and Capabilities in Population-based Cancer Screening
title Informed Decision-Making and Capabilities in Population-based Cancer Screening
title_full Informed Decision-Making and Capabilities in Population-based Cancer Screening
title_fullStr Informed Decision-Making and Capabilities in Population-based Cancer Screening
title_full_unstemmed Informed Decision-Making and Capabilities in Population-based Cancer Screening
title_short Informed Decision-Making and Capabilities in Population-based Cancer Screening
title_sort informed decision-making and capabilities in population-based cancer screening
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883722/
https://www.ncbi.nlm.nih.gov/pubmed/36727101
http://dx.doi.org/10.1093/phe/phac023
work_keys_str_mv AT boltinekelle informeddecisionmakingandcapabilitiesinpopulationbasedcancerscreening
AT schermermaartjehn informeddecisionmakingandcapabilitiesinpopulationbasedcancerscreening
AT bomhofroordinkhanna informeddecisionmakingandcapabilitiesinpopulationbasedcancerscreening
AT timmermansdaniellerm informeddecisionmakingandcapabilitiesinpopulationbasedcancerscreening